MetaCap

Cumberland Pharmaceuticals (CPIX) vs Nkarta (NKTX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals (CPIX) has outperformed Nkarta (NKTX) over the past year, gaining 193.5% versus a loss of 36.9%. Over five years, CPIX leads with a +161.9% price change compared with -93.0% for NKTX. Cumberland Pharmaceuticals is the larger company by market cap ($87.6 million vs $81.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+193.47%NKTX-36.94%
+370%+156%-57%
Nov 21, 20251 yearNov 20, 2026
CPIX+134.54%NKTX-93.47%
+258%+74%-110%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus NKTX key metrics
MetricCPIXNKTX
Share price$5.84$1.14
Market cap$87.57M$81.29M
1-day change-7.30%+1.34%
YTD return+46.73%-38.65%
1-year return+193.47%-36.94%
5-year return+161.88%-93.05%
Forward P/E41.71—
EPS (TTM)$-0.57$-1.73
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M$0
Revenue growth (YoY)+17.57%—
Net income (latest FY)$-2.84M$-104.08M
Gross margin85.02%—
Operating margin-6.27%—
Net margin-6.37%—
52-week high$9.28$3.72
52-week low$2.00$1.11
Distance from 52-week high-37.07%-69.49%
Analyst consensus—strong_buy
Avg. price target upside—+825.11%
Average volume114.52K1.02M
Shares outstanding15.00M71.62M
Employees88108
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CPIX has outperformed NKTX by 230.4 percentage points over the past year.

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About Nkarta

NKTX stock →

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis.

Health Care · Biotechnology: Pharmaceutical Preparations · 108 employees

CPIX vs NKTX FAQ

Which is bigger, Cumberland Pharmaceuticals or Nkarta?

Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $87.57M compared with $81.29M for Nkarta (NKTX).

Which stock has performed better over the past year, CPIX or NKTX?

CPIX returned +193.47% over the past 12 months, compared with -36.94% for NKTX (price return, excluding dividends). Past performance does not predict future results.

Are Cumberland Pharmaceuticals and Nkarta in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons